Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5584524 | Journal of the American Society of Cytopathology | 2017 | 9 Pages |
Abstract
A variety of BST lesions-including neoplasms not typically thought to have neuroendocrine differentiation-can possess NE cytomorphologic features and/or NE IHC marker positivity. The patient's clinical presentation and history can help narrow the differential diagnosis.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Clinical Biochemistry
Authors
Derek B. MD, Austin MD, Christopher J. MD, PhD,